Laser versus sham for genitourinary syndrome of menopause: A randomised controlled trial.

Ann-Sophie PageJan Y VerbakelJohan VerhaegheYani P LatulSusanne HousmansJan A Deprest

Published in: BJOG : an international journal of obstetrics and gynaecology (2022)

In women with GSM, the treatment response 12 weeks after laser application was comparable to that of sham applications. There were no obvious differences for secondary outcomes and no serious adverse events were reported.

Keyphrases

double blind
high speed
postmenopausal women
case report
type diabetes
insulin resistance